WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 122
GDP / capita (US$): 13'4481 Child (under 5 years) mortality rate: 132

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 284  283  283  282  281  270  260  252 
Births
Surviving infants
Pop. less than 5 years 17  17  17  17  17  19  21  22 
Pop. less than 15 years 55  55  55  55  55  59  63  75 
Female 15-49 years 68  69  69  70  71  74  73  64 

Number of reported cases

(Click for retrospective incidence data for Barbados)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  51  27 
Mumps
ChartChart
 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  13 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Barbados)
Vaccine year result method % card seen                                                
BCG          38  62  92  95 
DTP1          96  98  93 
DTP3          97  94  91  87  91  93  91  60 
DTP4          85 
IPV1          99 
HepB_BD         
HepB3          97  94  91  87  91 
Hib3          97  94  91  87  91 
JapEnc         
MCV1          96  95  87  90  93  94  87  41 
MCV2          89  91  89  90  94 
PCV1          98  94 
PCV3          97  90 
Pol3          97  95  91  88  91  86  90  99 
Rota1         
RotaC         
Rubella1          96  95  87  90  93 
TT2plus          20 
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Barbados)
DTP1
ChartChart
  99  98  97  96  95  93  97  82 
DTP3
ChartChart
  97  94  91  87  91  93  91  60 
HepB3
ChartChart
  97  94  91  87  91 
HepB_BD
ChartChart
 
Hib3
ChartChart
  97  94  91  87  91 
IPV1
ChartChart
 
MCV1
ChartChart
  96  95  87  90  93  94  87  41 
MCV2
ChartChart
  89  91  89  90  94 
PCV3
ChartChart
  97  90  87  84  81 
Pol3
ChartChart
  97  95  91  88  91  86  90  99 
RCV1
ChartChart
  96  95  87  90  93  94  87 
RotaC
ChartChart
 

Number of districts in the country 10  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 90
From 80 to 89% 0
From 50 to 79% 10
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 5 years; Yes
DT 5-7 years; Yes
DTwP 18 months; 4.5 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HPV 11 years (x3); Yes
HepB Yes adults
IPV 2, 4, 6, 18 months; 4.5, 10-11 years; Yes children of HIV mothers and from October to all children (1st and 2nd dose)
Influenza_Adult >= 65 years; Yes health care workers and other risk groups
MMR 1, 3-5 years; Yes
OPV 2, 4, 6, 18 months; 4.5, 10-11 years; Yes
Pneumo_conj 2, 4, 6 months; Yes
Td 10-11 years; Yes
Varicella 1 year; Yes
YF > 1 year; Yes Travelers

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  Yes  No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number  

System performance

Total Nº districts in country number 11 
Nº districts with DTP3 coverage >=80% number 11       
% of districts with DTP3 coverage >=80% From 0 to 100% 100        100 
Nº districts with measles (MCV1) coverage >=95% number      
% of districts with MCV1 coverage >=95% From 0 to 100% 36       

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No      Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes      Yes      Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 99      98  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.